attachment

Answer all the above questions in detail

Reading File
Given the breadth of this exam (12 questions across biochemistry), I'll use parallel searches across all topics to maximize efficiency.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I've exhausted my query_library_db calls. I have enough context from the library snippets and my training knowledge to provide comprehensive answers to all 12 questions. Let me now compile detailed answers.Here are detailed answers to all 12 questions:

NARAYANA MEDICAL COLLEGE — Biochemistry 2nd Internal Assessment


ESSAY QUESTIONS (15 marks each)


Q1. Vitamin D: Synthesis, Biochemical Functions, Daily Requirement, Sources, and Deficiency Manifestations

Structure

Vitamin D is a fat-soluble steroid hormone. The two main forms are:
  • Vitamin D₂ (Ergocalciferol) — from plants/fungi
  • Vitamin D₃ (Cholecalciferol) — from animal sources and skin synthesis

Synthesis of Vitamin D (Step-by-step)

7-Dehydrocholesterol (in skin)
        ↓  [UV light / sunlight, 290–315 nm]
Previtamin D₃  →  Vitamin D₃ (Cholecalciferol)
        ↓  [Liver: 25-hydroxylase / CYP27A1]
25-Hydroxycholecalciferol [25(OH)D₃] — major storage form
        ↓  [Kidney: 1α-hydroxylase / CYP27B1]  ← PTH stimulates; Ca²⁺ inhibits
1,25-Dihydroxycholecalciferol [1,25(OH)₂D₃]
       = CALCITRIOL — the active form
Regulation:
  • PTH ↑ → activates renal 1α-hydroxylase → more calcitriol
  • Low serum Ca²⁺/PO₄³⁻ → stimulates calcitriol production
  • 24,25-dihydroxycholecalciferol is the inactive/storage metabolite (formed by 24-hydroxylase)

Daily Requirement

GroupRequirement
Adults (19–70 yrs)600 IU/day (15 µg/day)
Elderly (>70 yrs)800 IU/day (20 µg/day)
Infants400 IU/day
Pregnancy/Lactation600 IU/day

Dietary Sources

SourceContent
Cod liver oilRichest source
Fatty fish (salmon, mackerel, tuna)High
Egg yolk, liverModerate
Fortified milk, cerealsVariable
SunlightMajor endogenous source (15–30 min/day)

Biochemical Functions of Vitamin D (Calcitriol)

  1. Intestinal Ca²⁺ absorption:
    • Calcitriol binds to nuclear VDR (Vitamin D Receptor)
    • Induces synthesis of Calbindin-D (calcium-binding protein)
    • Increases transcellular absorption of Ca²⁺ and phosphate from gut
  2. Bone mineralization:
    • Promotes osteoblast activity and calcium deposition
    • Maintains adequate serum Ca²⁺ × PO₄³⁻ product for hydroxyapatite formation
    • At high doses: promotes osteoclast activity → bone resorption
  3. Renal reabsorption:
    • Enhances reabsorption of Ca²⁺ and phosphate in distal tubules
  4. Parathyroid gland:
    • Suppresses PTH synthesis (negative feedback)
  5. Immunomodulation:
    • Activates macrophages; anti-inflammatory; reduces risk of autoimmune diseases
  6. Cell differentiation:
    • Promotes differentiation and inhibits proliferation (anticancer role)
  7. Muscle function:
    • Required for normal muscle contraction; deficiency causes myopathy

Deficiency Manifestations

In Children — RICKETS

  • Defective mineralization of growing bones
  • Craniotabes (softening of skull)
  • Frontal bossing (prominent forehead)
  • Rachitic rosary (beading at costochondral junctions)
  • Harrison's sulcus (horizontal groove at diaphragm)
  • Bow legs (genu varum) or knock knees (genu valgum)
  • Widened epiphyses (wrist widening — "rickety rosary of wrist")
  • Delayed dentition; dental caries
  • Hypocalcemia → tetany, convulsions

In Adults — OSTEOMALACIA

  • Softening of bones due to inadequate mineralization
  • Bone pain, muscle weakness, fractures
  • Looser zones (pseudo-fractures) on X-ray
  • Waddling gait

Biochemical findings in rickets/osteomalacia:

  • ↓ Serum Ca²⁺, ↓ Serum PO₄³⁻
  • ↑ Serum Alkaline Phosphatase (ALP)
  • ↑ PTH

Other deficiency effects:

  • Osteoporosis (elderly)
  • Increased susceptibility to infections
  • Muscle weakness (proximal myopathy)

Q2. Metabolism of Phenylalanine and Tyrosine; Biologically Important Products; Inborn Errors

Overview

Both phenylalanine (essential) and tyrosine (non-essential if Phe is adequate) are aromatic amino acids. Phenylalanine is converted to tyrosine as the first step in its catabolism.

Metabolism Pathway

Phenylalanine
    ↓  [Phenylalanine hydroxylase + BH4 (tetrahydrobiopterin)]
Tyrosine
    ├──→ Catecholamines (DOPA → Dopamine → Norepinephrine → Epinephrine)
    ├──→ Thyroid hormones (T3, T4)
    ├──→ Melanin (via DOPA → Dopaquinone → Melanin)
    ├──→ Fumarate + Acetoacetate (energy catabolism)
    └──→ Homogentisate pathway

Catabolism (convergent pathway):

Tyrosine
  ↓ [Tyrosine aminotransferase]
p-Hydroxyphenylpyruvate
  ↓ [p-hydroxyphenylpyruvate dioxygenase]
Homogentisate
  ↓ [Homogentisate oxidase]
Maleylacetoacetate
  ↓
Fumarylacetoacetate
  ↓
Fumarate + Acetoacetate  (→ TCA cycle + ketone bodies)
Phenylalanine and tyrosine are both glucogenic AND ketogenic.

Biologically Important Products

ProductDerived FromFunction
TyrosinePhenylalanineProtein synthesis; precursor for multiple products
DopamineTyrosine (via DOPA)Neurotransmitter; reward pathway
NorepinephrineDopamineNeurotransmitter; fight-or-flight
Epinephrine (Adrenaline)NorepinephrineHormone; glycogenolysis, lipolysis
Thyroxine (T₄)Tyrosine + iodineThyroid hormone; regulates BMR
Triiodothyronine (T₃)T₄ deiodinationActive thyroid hormone
MelaninTyrosine → DOPASkin/hair/eye pigment; photoprotection
FumarateTyrosine catabolismTCA cycle intermediate
AcetoacetateTyrosine catabolismKetone body
Catecholamine synthesis pathway:
Tyrosine → [Tyrosine hydroxylase, BH4] → DOPA
  → [DOPA decarboxylase] → Dopamine
  → [Dopamine β-hydroxylase] → Norepinephrine
  → [PNMT, SAM] → Epinephrine

Inborn Errors of Metabolism

DiseaseEnzyme DefectAccumulated MetaboliteFeatures
Phenylketonuria (PKU)Phenylalanine hydroxylase (PAH)Phenylalanine, phenylpyruvate, phenyllactateIntellectual disability, musty odor, fair skin/hair, eczema; treat: low-Phe diet + tyrosine supplementation
Malignant PKUBH4 synthesis or regeneration enzymes (GTP cyclohydrolase, DHPR)Phenylalanine + ↓neurotransmittersSevere neurological deficit; BH4 + neurotransmitter precursors needed
Tyrosinemia Type IFumarylacetoacetaseFumarylacetoacetate, succinylacetoneLiver failure, hepatocellular carcinoma; treat: NTBC
Tyrosinemia Type II (Richner-Hanhart)Tyrosine aminotransferaseTyrosinePalmoplantar keratosis, corneal ulcers, intellectual disability
AlkaptonuriaHomogentisate oxidaseHomogentisic acidUrine turns black on standing, ochronosis (blue-black pigmentation in connective tissue), arthritis
AlbinismTyrosinase (or related)None accumulatesAbsence of melanin; photophobia, nystagmus, pale skin/hair/eyes

SHORT ESSAY QUESTIONS (10 marks each)


Q3. Products Obtained from Glycine

Glycine is the simplest amino acid (no chiral center) and is a major metabolic precursor:

1. Heme (Porphyrins)

  • Glycine + Succinyl-CoA → δ-Aminolevulinic acid (ALA) [by ALA synthase, rate-limiting; requires pyridoxal phosphate]
  • 8 ALA → Protoporphyrin IX → Heme (with Fe²⁺)

2. Purines

  • Glycine contributes C4, C5, N7 of the purine ring
  • Essential for de novo purine synthesis

3. Glutathione (GSH)

  • Tripeptide: Glu–Cys–Gly
  • Glycine is the third amino acid
  • Key antioxidant

4. Creatine

  • Glycine + Arginine → Guanidinoacetate [in kidney]
  • Guanidinoacetate + methyl group (from SAM) → Creatine [in liver]
  • Creatine → Creatine phosphate (energy storage in muscle)

5. Conjugated Bile Acids

  • Cholic acid + Glycine → Glycocholic acid (bile salt)
  • Facilitates fat digestion/absorption

6. Hippuric Acid

  • Benzoic acid + Glycine → Hippuric acid
  • Detoxification product; excreted in urine

7. Serine and One-Carbon Units

  • Glycine ↔ Serine (reversible; serine hydroxymethyltransferase + THF)
  • Provides 1-carbon units for methylation reactions

8. Glycine as Neurotransmitter

  • Inhibitory neurotransmitter in spinal cord and brainstem

9. Glyoxylate and Oxalate

  • Glycine → Glyoxylate → Oxalate (risk for kidney stones if excess)

10. Collagen

  • Glycine is every third residue in collagen (Gly-X-Y repeat) — essential for triple helix structure

Q4. Purine Catabolism

Purines (Adenine and Guanine) from nucleic acid degradation are catabolized to uric acid in humans.

Pathway

AMP                          GMP
 ↓ [5'-nucleotidase]         ↓ [5'-nucleotidase]
Adenosine                   Guanosine
 ↓ [Adenosine deaminase]     ↓ [Purine nucleoside phosphorylase]
Inosine                     Guanine
 ↓ [Purine nucleoside         ↓ [Guanase/Guanine deaminase]
    phosphorylase]
Hypoxanthine                Xanthine
      ↘                      ↗
       [Xanthine oxidase]
           Xanthine
              ↓ [Xanthine oxidase]
           Uric Acid (end product)
Key enzyme: Xanthine oxidase (requires molybdenum as cofactor)

Uric Acid

  • End product in humans, great apes, Dalmatian dogs
  • Other mammals have uricase → allantoin → urea
  • Normal serum uric acid: Men: 3.5–7.2 mg/dL; Women: 2.6–6.0 mg/dL
  • Excreted mainly by kidneys (~70%) and gut (~30%)

Clinical Significance

ConditionMechanismFeatures
GoutHyperuricemia → monosodium urate crystals in jointsAcute painful arthritis (1st MTP joint), tophi, nephropathy
Lesch-Nyhan SyndromeHGPRT deficiency → ↑↑ uric acidSelf-mutilation, choreoathetosis, gout (see Q11)
Allopurinol (drug)Inhibits xanthine oxidaseTreats gout by reducing uric acid

Salvage Pathway (recap)

  • HGPRT: Hypoxanthine + PRPP → IMP; Guanine + PRPP → GMP
  • APRT: Adenine + PRPP → AMP
  • Saves energy vs. de novo synthesis

Q5. Iron Absorption and Mucosal Block Theory

Forms of dietary iron

  • Haem iron (Fe²⁺ in heme) — from meat; 20–30% absorbed; direct uptake via HCP1
  • Non-haem iron (Fe³⁺) — from plants; 1–5% absorbed; must be reduced to Fe²⁺ first

Steps of Iron Absorption

LUMEN                           ENTEROCYTE               BLOOD
Fe³⁺ [dietary]
  ↓ [Duodenal cytochrome b (DcytB), vitamin C helps]
Fe²⁺
  ↓ [DMT-1 (Divalent Metal Transporter 1)]
                       Fe²⁺ in enterocyte
                       ↙              ↘
              [stored as Ferritin]    [Ferroportin → exports Fe²⁺]
                                           ↓ [Hephaestin, copper-enzyme]
                                         Fe³⁺
                                           ↓ [Transferrin in plasma]
                                    Transferrin-Fe³⁺ complex

Mucosal Block Theory (Hahn, 1943)

  • Proposed that the intestinal mucosal cell acts as a "block" to prevent iron overload
  • When iron stores are replete:
    • Intracellular ferritin levels rise in enterocytes
    • Incoming Fe²⁺ is stored as ferritin rather than exported
    • When the enterocyte is shed (every 3–5 days), stored iron is lost
    • This limits further absorption → "mucosal block"
  • When body needs more iron:
    • Ferritin synthesis decreases
    • More iron is exported via ferroportin
  • Hepcidin (from liver) is the master regulator:
    • ↑ Hepcidin → degrades ferroportin → blocks iron export → reduces absorption
    • ↑ Iron stores, infection, inflammation → ↑ Hepcidin
    • ↓ Iron stores, hypoxia, erythropoiesis → ↓ Hepcidin

Factors enhancing absorption

  • Ascorbic acid (Vitamin C) — reduces Fe³⁺ → Fe²⁺
  • HCl (gastric acid) — keeps iron soluble
  • Meat factor
  • Low body iron stores

Factors reducing absorption

  • Phytates (cereals), oxalates (spinach)
  • Phosphates, tannins (tea/coffee)
  • Antacids (↑ pH)
  • ↑ Body iron stores (via hepcidin)

Q6. Functions of Glutathione

Structure: Tripeptide — γ-Glutamyl–Cysteinyl–Glycine (GSH)
  • The sulfhydryl (–SH) group of cysteine is the active site
  • Exists in reduced (GSH) and oxidized (GSSG) forms
  • GSH:GSSG ratio normally >10:1 in cells
  • Regenerated by Glutathione reductase using NADPH

Functions

  1. Antioxidant (primary role)
    • 2 GSH + H₂O₂ → GSSG + 2H₂O [by Glutathione peroxidase]
    • Neutralizes free radicals and reactive oxygen species (ROS)
  2. Protection of RBCs
    • Reduces oxidized hemoglobin (MetHb → Hb)
    • Maintains membrane protein thiols
    • Deficiency of G6PD → ↓ NADPH → ↓ GSH → RBC hemolysis (G6PD deficiency)
  3. Detoxification / Conjugation
    • GSH conjugates with xenobiotics (drugs, carcinogens) in Phase II liver detoxification
    • GSH + Paracetamol toxic metabolite (NAPQI) → safe conjugate
    • Mercapturic acid pathway
  4. Amino acid transport (γ-glutamyl cycle)
    • γ-Glutamyl transpeptidase transfers Glu from GSH to amino acids on cell surface
    • Transports amino acids across cell membranes (especially kidney, intestine)
    • Meister cycle — active transport of amino acids
  5. Reduction of ribonucleotides
    • Ribonucleotide reductase uses glutaredoxin (reduced by GSH) to make deoxyribonucleotides
  6. Maintenance of protein –SH groups
    • Keeps enzyme active-site cysteines in reduced (active) state
  7. Leukotriene synthesis
    • GSH is substrate for leukotriene (eicosanoid) synthesis
  8. Sperm function
    • High GSH in sperm; protects from oxidative damage

Q7. Van Den Berg Reaction

Definition

The Van den Bergh reaction (1916) is a chemical test to measure serum bilirubin levels using Ehrlich's diazo reagent (diazotized sulfanilic acid).

Principle

  • Bilirubin + Diazo reagent → Azobilirubin (purple-pink color)
  • The reaction gives a pink/violet color measured at 540 nm

Types of Bilirubin

PropertyDirect BilirubinIndirect Bilirubin
FormConjugated (glucuronide)Unconjugated
SolubilityWater-solubleLipid-soluble (bound to albumin)
ReactionReacts directly with diazo reagent without alcoholRequires alcohol to react
Van den BerghDirect reactionIndirect reaction
Crosses BBBNoYes (neurotoxic)

Procedure

  • Direct bilirubin (conjugated): Sample + diazo reagent → pink color in aqueous medium within 1 min
  • Total bilirubin: Sample + methanol (alcohol) + diazo reagent → all bilirubin reacts
  • Indirect bilirubin (unconjugated): Total − Direct

Normal Values

FractionNormal value
Total bilirubin0.2–1.0 mg/dL
Direct (conjugated)0.0–0.2 mg/dL
Indirect (unconjugated)0.2–0.8 mg/dL

Clinical Significance

TypeDirect ↑Indirect ↑
CauseObstructive jaundice, hepatocellular diseaseHemolytic jaundice, Gilbert's, Crigler-Najjar
Urine bilirubinPresent (bilirubinuria)Absent
StercobilinogenReduced (clay stools)Increased
KernicterusNot causedRisk in neonates (indirect crosses BBB)

Q8. Products of Transmethylation

Definition

Transmethylation is the transfer of a methyl group (–CH₃) from a donor to an acceptor. The universal methyl donor is S-Adenosylmethionine (SAM) (also called "active methionine").

Formation of SAM

Methionine + ATP → S-Adenosylmethionine (SAM)   [by Methionine adenosyltransferase]

Products of Transmethylation via SAM

Methyl AcceptorProductEnzymeSignificance
GuanidinoacetateCreatineGuanidinoacetate methyltransferaseEnergy storage in muscle
NorepinephrineEpinephrine (Adrenaline)PNMT (Phenylethanolamine-N-methyltransferase)Adrenal hormone
PhosphatidylethanolaminePhosphatidylcholine (Lecithin)PE N-methyltransferaseCell membrane phospholipid; VLDL synthesis
AcetylserotoninMelatoninHIOMTSleep hormone; circadian rhythm
EthanolamineCholineNeurotransmitter precursor; lipid metabolism
DNA basesMethylated DNADNA methyltransferaseGene silencing, epigenetics
RNA basesMethylated RNAtRNA/rRNA methylasestRNA stability
HistamineMethylhistamineHistamine methyltransferaseHistamine inactivation
NicotinamideN-MethylnicotinamideNicotinamide methyltransferaseNiacin catabolism
Homocysteine (re-methylation)MethionineMethionine synthase (B₁₂)SAM regeneration

After Methylation: SAM → SAH

SAM + Acceptor → SAH (S-Adenosylhomocysteine) + Methylated product
SAH → Adenosine + Homocysteine [by SAH hydrolase]
Homocysteine → Methionine [by methionine synthase, needs B₁₂ + folate]
         or → Cystathionine → Cysteine [transsulfuration, needs B₆]

Q9. Calcium Homeostasis

Normal values

  • Total serum calcium: 8.5–10.5 mg/dL (2.1–2.6 mmol/L)
  • Ionized (free) Ca²⁺: 4.5–5.5 mg/dL (~50%)
  • Protein-bound: ~40% (mainly albumin)
  • Complexed: ~10%

Body distribution

  • 99% in bone (hydroxyapatite)
  • 1% in blood and soft tissues

Three Hormones Regulating Calcium

1. Parathyroid Hormone (PTH)

  • Released when serum Ca²⁺ ↓
  • Bone: ↑ Osteoclast activity → ↑ Ca²⁺ and PO₄³⁻ release
  • Kidney: ↑ Ca²⁺ reabsorption (distal tubule); ↓ PO₄³⁻ reabsorption; activates 1α-hydroxylase → ↑ calcitriol
  • Gut: Indirect (via calcitriol) → ↑ Ca²⁺ absorption
  • Net: ↑ serum Ca²⁺, ↓ serum PO₄³⁻

2. Vitamin D (Calcitriol — 1,25(OH)₂D₃)

  • Activated by PTH in kidney
  • Gut: ↑ Ca²⁺ and PO₄³⁻ absorption (via calbindin-D synthesis)
  • Bone: At physiological levels → promotes mineralization; at high levels → resorption
  • Kidney: ↑ Ca²⁺ reabsorption
  • Net: ↑ serum Ca²⁺ and PO₄³⁻

3. Calcitonin

  • Released from parafollicular (C) cells of thyroid when Ca²⁺ ↑
  • Bone: ↓ Osteoclast activity → ↓ Ca²⁺ release
  • Kidney: ↑ Ca²⁺ and PO₄³⁻ excretion
  • Net: ↓ serum Ca²⁺ (opposes PTH)

Summary diagram:

Low Ca²⁺ → ↑PTH → ↑ Bone resorption, ↑ Renal Ca²⁺ reabsorption, ↑ Calcitriol
                 ↓
           ↑ Gut absorption (calcitriol)
                 ↓
           ↑ Serum Ca²⁺ → negative feedback → ↓ PTH; ↑ Calcitonin

Clinical Disorders

DisorderMechanismFeatures
Hypocalcemia↓ PTH, ↓ Vit D, ↓ Mg²⁺Tetany, Trousseau's, Chvostek's, convulsions
Hypercalcemia↑ PTH (hyperparathyroidism), malignancyStones, bones, groans, moans (renal stones, bone pain, constipation, confusion)
Rickets/Osteomalacia↓ Vitamin D(see Q1)

Q10. Transmethylation and Deamination

A. TRANSMETHYLATION

(Detailed answer covered in Q8 above — brief summary here)
  • Transfer of methyl group (–CH₃) from SAM to various acceptors
  • SAM = "active methionine" (methionine + ATP)
  • Products: creatine, epinephrine, phosphatidylcholine, melatonin, methylated DNA/RNA
SAM cycle:
Methionine + ATP → SAM → [Methylation] → SAH → Homocysteine → (back to Methionine via B₁₂/folate)

B. DEAMINATION

Deamination is the removal of an amino group (–NH₂) from amino acids, releasing ammonia (NH₃) and producing keto acids.

Types of Deamination:

1. Oxidative Deamination (most important)
Glutamate + NAD⁺ → α-Ketoglutarate + NH₃ + NADH
[Enzyme: Glutamate dehydrogenase, in liver mitochondria; requires NAD⁺ or NADP⁺]
  • Allosteric inhibited by GTP, NADH (energy surplus)
  • Activated by ADP, NAD⁺ (energy deficit)
  • This is the major source of free ammonia for urea synthesis
2. Transamination (NOT true deamination, but linked)
Amino acid + α-Ketoglutarate → Keto acid + Glutamate [by aminotransferases, PLP]
Glutamate → deaminated by GDH → releases NH₃
3. Non-oxidative Deamination
  • Serine → Pyruvate + NH₃ [serine dehydratase, B₆]
  • Threonine → α-ketobutyrate + NH₃ [threonine dehydratase]
  • Cysteine → Pyruvate + NH₃ + H₂S
4. Oxidase type (D-amino acids)
  • D-amino acid oxidase: D-amino acids + O₂ → keto acid + NH₃ + H₂O₂

Fate of NH₃:

  • In liver → Urea cycle (detoxification)
  • In brain/peripheral tissues → Glutamine synthesis (Glu + NH₃ → Glutamine, by glutamine synthetase)
  • In kidney → Excreted as NH₄⁺ (acid-base regulation)

Clinical: Hyperammonemia

  • Urea cycle enzyme defects → toxic accumulation of NH₃
  • Symptoms: encephalopathy, vomiting, cerebral edema, coma
  • NH₃ depletes α-ketoglutarate → TCA cycle impaired

Q11. Lesch-Nyhan Syndrome and Orotic Aciduria

A. LESCH-NYHAN SYNDROME

Definition: X-linked recessive disorder of purine metabolism.
Enzyme defect: Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT) — complete absence
Gene: HPRT1 gene on X chromosome
Mechanism:
  • HGPRT normally salvages hypoxanthine and guanine back to IMP and GMP
  • In its absence, hypoxanthine and guanine cannot be recycled
  • PRPP accumulates → drives de novo purine synthesis → excess purine catabolism → ↑↑ Uric acid
  • Loss of IMP/GMP feedback → unregulated PRPP amidotransferase
Features:
FeatureDetails
HyperuricemiaGout, uric acid stones, renal failure
Self-mutilationCompulsive biting of fingers, lips, and buccal mucosa — pathognomonic
NeurologicalChoreoathetosis, spasticity, intellectual disability, dystonia
Onset3–6 months; appears normal at birth
InheritanceX-linked recessive (males affected, females carriers)
Laboratory: ↑↑ Uric acid, absent HGPRT activity in RBCs/fibroblasts
Treatment:
  • Allopurinol — reduces uric acid (controls gout/stones but NOT neurological symptoms)
  • No cure; neurological damage is irreversible

B. OROTIC ACIDURIA

Definition: Inborn error of pyrimidine (not purine) de novo synthesis.
Types:
TypeEnzyme DefectFeatures
Type I (Classic)UMP synthase (bifunctional enzyme: OPRT + ODC) — both activities absentMost common type
Type IIODC (orotidine decarboxylase) only — OPRT activity presentVery rare
Mechanism:
  • Orotic acid is an intermediate in pyrimidine synthesis pathway
  • CAD → Orotic acid → [OPRT] → Orotidine-5'-phosphate → [ODC] → UMP
  • Enzyme defect → orotic acid cannot proceed → accumulates → excreted in urine
Also caused by:
  • OTC (ornithine transcarbamylase) deficiency — accumulated carbamoyl phosphate is shunted into pyrimidine pathway → orotic acid overflow
  • Allopurinol therapy (minor orotic aciduria)
Clinical Features:
  • Megaloblastic anemia (not responsive to B₁₂ or folate)
  • Failure to thrive, growth retardation
  • Crystalluria (orotic acid crystals in urine)
  • Developmental delay (if untreated)
  • No hyperammonemia (distinguishes from OTC deficiency)
Diagnosis:
  • Elevated orotic acid in urine
  • Megaloblastic anemia unresponsive to B₁₂/folate
Treatment:
  • Uridine supplementation (bypasses the block)
    • Uridine → UMP → UTP → CTP (pyrimidines replenished)
    • UTP feedback-inhibits carbamoyl phosphate synthetase → reduces orotic acid accumulation

Q12. Urea Cycle — Illustrative Diagram

The Urea Cycle occurs mainly in liver hepatocytes (mitochondria + cytoplasm). It converts toxic NH₃ to non-toxic urea for excretion by kidneys.

Enzymes, substrates, and products:

                    MITOCHONDRIA
                    ┌────────────────────────────────┐
                    │                                │
  NH₃ + CO₂        │                                │
  (from GDH)       │                                │
       ↓            │                                │
  Carbamoyl phosphate                               │
  [CPS-I: Carbamoyl  ← 2 ATP                        │
   Phosphate         ← H₂O                          │
   Synthetase I]     ← N-acetylglutamate (activator) │
       ↓            │                                │
  Carbamoyl phosphate + Ornithine                   │
       ↓ [OTC: Ornithine Transcarbamylase]           │
    CITRULLINE                                       │
       │             └────────────────────────────────┘
       │  (exits mitochondria via transporter)
       ↓
                    CYTOPLASM
    CITRULLINE + Aspartate  (ATP → AMP + PPᵢ)
       ↓ [ASS: Argininosuccinate Synthetase]
    ARGININOSUCCINATE
       ↓ [ASL: Argininosuccinate Lyase]
    ARGININE  +  Fumarate
       |                 ↓ (→ TCA cycle → regenerates aspartate)
       ↓ [Arginase + H₂O]
    ORNITHINE  +  UREA
       |
       ↓ (Ornithine re-enters mitochondria)

Summary Table of Urea Cycle Reactions

StepEnzymeLocationReaction
1Carbamoyl phosphate synthetase I (CPS-I)MitochondriaNH₃ + CO₂ + 2ATP → Carbamoyl phosphate
2Ornithine transcarbamylase (OTC)MitochondriaCarbamoyl-P + Ornithine → Citrulline
3Argininosuccinate synthetase (ASS)CytoplasmCitrulline + Aspartate + ATP → Argininosuccinate
4Argininosuccinate lyase (ASL)CytoplasmArgininosuccinate → Arginine + Fumarate
5ArginaseCytoplasmArginine + H₂O → Ornithine + Urea

Urea — key points:

  • 2 nitrogen atoms in urea: one from NH₃ (glutamate deamination), one from aspartate
  • 1 carbon from CO₂
  • Net cost: 3 ATP (4 high-energy bonds) per urea molecule
  • Urea is water-soluble; excreted by kidneys
  • Blood urea nitrogen (BUN): normal 7–20 mg/dL

Inborn errors of the Urea Cycle:

Enzyme DefectDiseaseKey Feature
CPS-ICPS-I deficiency↓ All cycle intermediates
OTCOTC deficiency (X-linked)Most common; ↑ orotic acid (distinguishes from CPS-I deficiency)
ASSCitrullinemia Type I↑ Citrulline
ASLArgininosuccinic aciduria↑ Argininosuccinate; trichorrhexis nodosa
ArginaseArgininemia↑ Arginine; spastic diplegia
All present with hyperammonemia, encephalopathy, vomiting.
---All 12 questions have been answered. Here is a quick navigation guide:

Quick Reference — All Questions Answered

#TopicKey Takeaway
Q1Vitamin D7-dehydrocholesterol → Cholecalciferol (UV) → 25(OH)D₃ (liver) → 1,25(OH)₂D₃ (kidney/calcitriol); functions: Ca²⁺/PO₄ homeostasis; deficiency: rickets (children), osteomalacia (adults)
Q2Phe & Tyr metabolismPhe → Tyr (PAH+BH4) → catecholamines/melanin/thyroid hormones/fumarate+acetoacetate; inborn errors: PKU, alkaptonuria, albinism, tyrosinemia
Q3Glycine productsHeme, purines, glutathione, creatine, conjugated bile acids, hippuric acid, serine, collagen, neurotransmitter
Q4Purine catabolismAMP/GMP → Hypoxanthine/Xanthine → Uric acid (xanthine oxidase); clinical: gout, Lesch-Nyhan
Q5Iron absorptionFe³⁺ → Fe²⁺ (DcytB) → DMT-1 → enterocyte → ferroportin → transferrin; mucosal block = ferritin storage when stores replete; hepcidin is master regulator
Q6GlutathioneAntioxidant (GPx), RBC protection, detoxification (Phase II), γ-glutamyl cycle (AA transport), NADPH-dependent regeneration
Q7Van den BergTests bilirubin with diazo reagent; Direct = conjugated (water-soluble); Indirect = unconjugated (needs alcohol); differentiates jaundice types
Q8Transmethylation productsSAM is methyl donor → creatine, epinephrine, lecithin, melatonin, methylated DNA/RNA
Q9Calcium homeostasisPTH (↑Ca²⁺), Calcitriol (↑Ca²⁺+PO₄), Calcitonin (↓Ca²⁺); 99% in bone; CaSR senses plasma Ca²⁺
Q10Transmethylation & DeaminationSAM cycle (methylation); Oxidative deamination by GDH releases NH₃ for urea cycle
Q11Lesch-Nyhan & Orotic aciduriaHGPRT deficiency → ↑↑ uric acid + self-mutilation + neurological damage; Orotic aciduria = UMP synthase defect → megaloblastic anemia, treat with uridine
Q12Urea cycle5 steps (CPS-I → OTC → ASS → ASL → Arginase); mitochondria + cytoplasm; 3 ATP; 2 N atoms in urea
This is a shared conversation. Sign in to Orris to start your own chat.